PHOENIX aims to revolutionize drug discovery and disease modelling by developing next-generation, human-based Organs-on-Chip (OoC) platforms. The project integrates advanced mechanical stimulation, high-resolution electrical recording, and real-time force sensing into a single modular ecosystem.
With the PHOENIX-SE (Safety Evaluation) expansion, the project scales its impact by introducing low-cost, screen-printed electronics. Our mission is to provide more predictive and human-relevant alternatives to animal testing, contributing to a meaningful reduction in animal use for cardiac safety screening in line with the EU's 3Rs principle (Replace, Reduce, Refine).
